SISU Aesthetic Clinic, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SISU Aesthetic Clinic, Inc. - overview
Established
2018
Location
Cork, -, Ireland
Primary Industry
Healthcare
About
Based in Ireland, SISU Aesthetic Clinic, Inc. specializes in cosmetic medicine, providing a wide range of aesthetic treatments that enhance natural beauty while prioritizing client satisfaction and personalized care. SISU Aesthetic Clinic, Inc. was founded in 2018 in Cork, Ireland, and focuses exclusively on aesthetic medicine.
The company has successfully raised a total of USD 5. 50 mn in investment, with the most recent funding round being a Series A in December 2024. The clinic operates under the leadership of CEO Pat Phelan, who, along with co-founders Brian Cotter and Jame Cotter, has a history of expertise in the field. The clinic has completed a total of 3 deals, aiming to expand its footprint in the cosmetic industry.
SISU Clinic specializes in cosmetic medicine, offering a diverse range of aesthetic treatments designed to enhance the natural beauty of its clients. The clinic's core offerings include Botox™ and Dysport™, aimed at reducing the appearance of fine lines and wrinkles, as well as lip enhancement through lip fillers and lip flips. Additionally, SISU Clinic provides treatments for under-eye hollows, jawline definition, and non-surgical rhinoplasty, among other injectable solutions tailored to individual client needs. The services are designed for both preventative and corrective measures, catering to a wide demographic that values youthful appearance and skin health.
SISU Clinic operates primarily in the United States, targeting urban areas with high demand for cosmetic procedures, ensuring that clients benefit from expert-led treatments and personalized care. In 2023, SISU Clinic reported a revenue of USD 13. 45 mn, though it also reported an EBITDA of USD -1. 69 mn for the same year.
The clinic generates revenue through direct-to-consumer transactions, with clients booking treatments for various cosmetic procedures at set prices. The pricing structure is transparent, with offerings such as Botox™ and Dysport™ priced at USD 495, and additional services like lip flips included within this package. Clients can expect a free consultation prior to treatment, leading to personalized plans based on individual goals. Each treatment is designed to deliver immediate and lasting results, reinforcing client trust and satisfaction in a competitive market.
In December 2024, SISU Aesthetic Clinic, Inc. raised USD 15 mn in venture debt funding from Structural Capital Partners to support group operations and expansion in the United States. The funding is strategically aimed at enhancing the clinic's operational capabilities and exploring new geographic markets. The company anticipates launching new products in the near future, enhancing its current offerings and expanding its reach.
Current Investors
Greycroft, Bullpen Capital, Gaingels
Primary Industry
Healthcare
Sub Industries
Clinics/Outpatient Services, Aesthetic Medicine, Dermatology
Website
www.sisuclinic.com/
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.